A team of engineers at the University of Wisconsin–Madison has created a process to improve the creation of synthetic neural stem cells for use in central nervous system research.
Category: Regenerative Biology
Thomson lab lands $2.2 million NIH grant
With a $2.2 million grant from the National Institutes of Health, stem cell pioneer Dr. James Thomson, University of Wisconsin–Madison associate professor of biomedical engineering William Murphy and School of Medicine and Public Health medical informatics professor David Page will lead a team to derive and assemble the distinct cell types found in the human cerebral cortex.
Study reveals critical similarity between two types of do-it-all stem cells
In a study published today (Sept. 11), researchers at the University of Wisconsin–Madison report the first full measurement of the proteins made by both types of stem cells. In a study that looked at four embryonic stem cells and four IPS cells, the proteins turned out to be 99 percent similar, says Joshua Coon, an associate professor of chemistry and biomolecular chemistry who directed the project.
Study shows patient’s own cells may hold therapeutic promise after reprogramming, gene correction
Scientists from the Morgridge Institute for Research, the University of Wisconsin–Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
Wisconsin, Morgridge scientists excise vector, exotic genes from induced stem cells
A team of scientists from the Morgridge Institute for Research at the University of Wisconsin–Madison reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.